BRIEF published on 04/17/2025 at 07:05, 11 months 5 days ago Evotec SE Outlines New Strategy with 2025 Guidance Following Strong Q4 2024 Performance Evotec SE 2025 Strategy Partnerships Growth Guidance Q4 2024 Results
PRESS RELEASE published on 04/17/2025 at 07:00, 11 months 5 days ago Evotec SE unveils new strategy and provides 2025 guidance bolstered by strong Q4 2024 results Evotec SE unveils new strategy and provides 2025 guidance with strong Q4 2024 results, focusing on drug discovery and sustainable growth Evotec SE Sustainable Growth New Strategy 2025 Guidance Q4 2024 Results
BRIEF published on 04/10/2025 at 11:30, 11 months 12 days ago Evotec SE publiera ses résultats financiers 2024 le 17 avril 2025 Résultats Financiers Evotec SE Webcast Conférence Téléphonique Thérapeutique
BRIEF published on 04/10/2025 at 11:30, 11 months 12 days ago Evotec SE to Release 2024 Financial Results on April 17, 2025 Financial Results Conference Call Evotec SE Webcast Therapeutics
PRESS RELEASE published on 04/10/2025 at 11:25, 11 months 12 days ago Evotec SE to announce results for financial year 2024 on 17 April 2025 Evotec SE to announce financial results for 2024 on April 17, 2025, followed by a conference call discussing strategic review and updates. Webcast and dial-in details provided Financial Results Conference Call Evotec SE Webcast Strategic Review
BRIEF published on 03/04/2025 at 07:35, 1 year ago La collaboration entre Evotec et Bristol Myers Squibb dans le domaine des neurosciences progresse Evotec SE Partenariat Stratégique Bristol Myers Squibb Neurodégénérescence Des Traitements Innovants
BRIEF published on 03/04/2025 at 07:35, 1 year ago Evotec's Neuroscience Collaboration with Bristol Myers Squibb Progresses Strategic Partnership Evotec SE Innovative Treatments Bristol Myers Squibb Neurodegeneration
PRESS RELEASE published on 03/04/2025 at 07:30, 1 year ago Evotec Announces Key Progress in Neuroscience Collaboration with Bristol Myers Squibb Evotec SE announces key progress in neuroscience collaboration with Bristol Myers Squibb, receiving a $20 million payment for neurodegeneration research Evotec SE Bristol Myers Squibb Neuroscience Collaboration Neurodegeneration Research Progress
BRIEF published on 02/26/2025 at 07:35, 1 year ago Evotec Announces Executive Transition in CFO Role Sustainable Growth Management Change Evotec Financial Leadership Paul Hitchin
BRIEF published on 02/26/2025 at 07:35, 1 year ago Evotec annonce une transition exécutive au poste de directeur financier Croissance Durable Changement De Direction Evotec Leadership Financier Paul Hitchin
Published on 03/23/2026 at 02:00, 2 hours 30 minutes ago FutureGen Industries Announces Open Market Investments
Published on 03/20/2026 at 13:30, 2 days 15 hours ago Unusual Machines Announces Pricing of Approximately $150 Million Public Offering of Common Stock
Published on 03/23/2026 at 03:35, 55 minutes ago Deye 2026 Frankfurt Distributor & Partner Summit Concludes Successfully
Published on 03/22/2026 at 12:23, 16 hours 7 minutes ago Borussia Dortmund and Sebastian Kehl are ending their collaboration with immediate effect
Published on 03/20/2026 at 22:45, 2 days 5 hours ago Investor Alert: Berger Montague (Canada) PC represents investors that purchased shares of Super Micro Computer, Inc. listed on the CBOE Canada and elsewhere
Published on 03/20/2026 at 21:05, 2 days 7 hours ago Fractal EMS Receives ISO/IEC 9001 and 27001 Certifications
Published on 03/20/2026 at 19:00, 2 days 9 hours ago AXA - Conditions for availability or consultation of information relating to AXA’s Shareholders’ Meeting of April 30, 2026
Published on 03/20/2026 at 19:00, 2 days 9 hours ago AXA - Modalités de mise à disposition ou de consultation des informations relatives à l’Assemblée Générale du 30 avril 2026
Published on 03/20/2026 at 18:15, 2 days 10 hours ago Publication of AXA’s 2025 Universal Registration Document
Published on 03/20/2026 at 18:15, 2 days 10 hours ago Mise à disposition du Document d’Enregistrement Universel 2025 d’AXA
